Identification, design, and in vivo proof of concept of a shared APC neoantigen delivered via a self-amplifying RNA containing virus-like nanoparticle for cancer vaccination - Poll - MDSpire

Identification, design, and in vivo proof of concept of a shared APC neoantigen delivered via a self-amplifying RNA containing virus-like nanoparticle for cancer vaccination

  • By

  • Alfred J. Simmons

  • Anna S. Nikonova

  • Chloe D. Jonas

  • Katherine A. Pniewski

  • Deepak Upreti

  • Maria I. Perez

  • Satish Adhikari

  • June 4, 2026

Share

Original Source(s)

Identification, design, and in vivo proof of concept of a shared APC neoantigen delivered via a self-amplifying RNA containing virus-like nanoparticle for cancer vaccination

  • by Alfred J. Simmons, Anna S. Nikonova, Chloe D. Jonas, Katherine A. Pniewski, Deepak Upreti, Maria I. Perez, Satish Adhikari

  • June 4, 2026

Related Content

Multimodal feature fusion model for breast mass malignant risk stratification

Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and literature review

Development and validation of a machine learning-based risk prediction model for cancer-related fatigue in ovarian cancer patients